Human Xtensions Ltd.

Tel Aviv Stock Exchange HUMX.TA

Human Xtensions Ltd. Price to Sales Ratio (P/S) on January 14, 2025: 1.69

Human Xtensions Ltd. Price to Sales Ratio (P/S) is 1.69 on January 14, 2025, a -65.34% change year over year. Price to sales ratio compares the stock price to the sales per share; higher suggests positive sentiment for future revenue growth.
  • Human Xtensions Ltd. 52-week high Price to Sales Ratio (P/S) is 5.51 on December 20, 2024, which is 227.10% above the current Price to Sales Ratio (P/S).
  • Human Xtensions Ltd. 52-week low Price to Sales Ratio (P/S) is 1.37 on November 11, 2024, which is -18.86% below the current Price to Sales Ratio (P/S).
  • Human Xtensions Ltd. average Price to Sales Ratio (P/S) for the last 52 weeks is 2.44.
Key data
Date Price to Sales Ratio (P/S) Price to Book Ratio (P/B) Dividend Yield Free Cash Flow Yield
Market news
Tel Aviv Stock Exchange: HUMX.TA

Human Xtensions Ltd.

CEO Dr. Tami Frenkel
IPO Date Dec. 2, 2020
Location Israel
Headquarters Meir Ariel 4
Employees 50
Sector Health Care
Industries
Medical Instruments
Description

Human Xtensions Ltd. develops, manufactures, markets and sells a modular medical device for minimally invasive surgical operations. It offers HandX, a handheld electromechanical device for use in laparoscopic procedures; Fenestrated Grasper; Monopolar Hook; and Needle Holder. The company was incorporated in 2012 and is based in Netanya, Israel.

StockViz Staff

January 15, 2025

Any question? Send us an email